Bilirubin
Cytochrome C
Gastric Mucin
HCG
FSH
UTI
PMSG
Aprotinin
Asparaginase
Beta Glucanase
Bromelain
Chymotrypsin
Kallikrein
Lysozyme
Pancreatin
Papain
Pepsin
Streptokinase
Trypsin
Urokinase
Coenzyme A
Coenzyme A Trilithium
Coenzyme Q10
Beta Glucans
Chitosan
Chondroitin Sulfate
Dextran
Dextran Sulfate Sodium
Glucosamine HCl
Heparin Sodium
Heparinoid
Hyaluronic Acid
Rosemary Extract
Sodium Cholate
Bilirubin
Cytochrome C
Gastric Mucin
HCG
FSH
UTI
PMSG
Aprotinin
Asparaginase
Beta Glucanase
Bromelain
Chymotrypsin
Kallikrein
Lysozyme
Pancreatin
Papain
Pepsin
Streptokinase
Trypsin
Urokinase
Coenzyme A
Coenzyme A Trilithium
Coenzyme Q10
Beta Glucans
Chitosan
Chondroitin Sulfate
Dextran
Dextran Sulfate Sodium
Glucosamine HCl
Heparin Sodium
Heparinoid
Hyaluronic Acid
Rosemary Extract
Sodium Cholate
Jiagen Biotechnologies
Proteins

Follicle Stimulating Hormone (FSH)

CAS No:9002-68-0
EINECS No:232-706-8
Synonyms:Follicle-stimulating gonadotropin, follitropin, FSH, hFSH, huFSH, human FSH, recombinant FSH (rFSH, follitropin alpha or beta), urofollitropin (urinary FSH)

Product Summary

Follicle Stimulating Hormone (FSH) is a heterodimeric glycoprotein hormone composed of two subunits and vital for reproductive processes. It plays essential roles in ovarian follicular maturation and testicular spermatogenesis. FSH, whether purified from human urine (urofollitropin) or produced recombinantly (follitropin alpha/beta), is used widely in both clinical treatments such as fertility therapy and in basic research. It functions through G-protein coupled receptor pathways and is central to studying reproductive physiology, endocrine disorders, and hormone-responsive cancers.

  • Formula (approximate): α-subunit, C960H1499N263O285S7; β-subunit, C907H1408N248O270S6
  • Molecular weight:~30–35 kDa (heavily glycosylated heterodimeric protein)

Function

  • Promotes the growth and maturation of ovarian follicles (primordial -> primary -> secondary -> antral follicles), and stimulates granulosa cell proliferation, increasing follicle size.
  • Induces aromatase enzyme in granulosa cells, converting androgens (from theca cells) into estradiol (E2).
  • Involves in the regulation of menstrual cycle.
  • Stimulates Sertoli cells to produce androgen-binding protein (ABP), which maintains high testosterone levels in the testes, and then activates spermatogenesis in males via
  • Supports nourishment and development of sperm cells (spermatogonia -> spermatocytes -> spermatids).

FSH is also a critical regulator of the hypothalamic-pituitary-gonadal axis.

Mechanism of Action

FSH binds to FSH receptors (FSHR) located on granulosa cells (ovary) or Sertoli cells (testes). FSH-FSHR interaction activates G-protein-coupled receptor signaling, leading to:

  • Increasing in cAMP production -> activates protein kinase A (PKA) -> phosphorylation of transcription factors (e. g. CREB) and then
  • Increased production of steroidogenic enzymes (aromatase, CYP19A1), grow factors (IGF-1, activin), estrogen, and inhibin, which
  • Promotes follicular development and gametogenesis

Applications in Scientific Research

  • Reproductive endocrinology studies (e.g. follicular development, ovulation mechanisms).
  • Used in studies aiming at developing variants of assisted reproductive technology (ART) protocols.
  • Studies on FSH receptor signaling and mutations, aiding in designing selective agonists/antogonists.
  • Research in infertility treatment and hormone replacement therapy.
  • Investigations of gonadotropin regulation and feedback mechanisms in the HPG axis.
  • Comparative endocrinology in mammals and vertebrates.
  • Evaluating the role of FSH in aging, bone metabolism, and certain cancers.

Packaging & Storage

  • Sources: purified from human urine (postmenopausal women – urofollitropin)
  • Available as almost white to slightly yellowish lyophilized powder
  • Store in a sterile, airtight, tamper-proof container, protected from light, at a temperature of 2°C to 8°C

References

  1. Mahony MC, et al. 2021: Recombinant human follicle-stimulating hormone alfa dose adjustment in US clinical practice: An observational, retrospective analysis of a real-world electronic medical records database, Front Endocrinol (Lausanne) 12: 742089.
  2. Gibreel A, Bhattacharya S. 2010: Recombinant follitropin alfa/lutropin alfa in fertility treatment, Biologics 4: 5–17.
  3. Bouloux P, et al. 2002: Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism, Fertil Steril. 77(2): 270–3.
  4. Liu X. 2015: Efficacy of highly purified urinary FSH versus recombinant FSH in Chinese women over 37 years undergoing assisted reproductive techniques, Int J Fertil Steril. 8(4): 385–92.
  5. Bordewijk EM, et al. 2019: Required amount of rFSH, HP-hMG and HP-FSH to reach a live birth: a systematic review and meta-analysis, Hum Reprod Open. 2019(3): hoz008.
  6. Lispi M, et al. 2006: Comparative assessment of the consistency and quality of a highly purified FSH extracted from human urine (urofollitropin) and a recombinant human FSH (follitropin alpha), Reprod Biomed Online. 13(2): 179–93.
  7. Vitt VA, et al. 1998: Isoforms of human recombinant follicle-stimulating hormone: comparison of effects on murine follicle development in vitro, Biol Reprod. 59(4): 854–61.
  8. Dias JA, van Roey P. 2001: Structural biology of human follitropin and its receptor, Arch Med Res. 32(6): 510–9.
  9. De Pascali F, et al. 2018: Follicle-stimulating hormone receptor: Advances and remaining challenges, Int Rev Cell Mol Biol. 338: 1–58.
  10. Ayoub MA, et al. 2016: Computational modeling approaches in gonadotropin signaling, Theriogenology 86(1): 22–31.
  11. Hungues N-J. 2001: Recombinant human follicle-stimulating hormone: a scientific step to clinical improvement, Reprod BioMed Online. 2(1): 54–64.
  12. Smitz J, et al. 2016: Follicle-stimulating hormone: A review of form and function in the treatment of infertility, Reprod Sci. 23(6): 706–16.
  13. Pang SC. 2005: Use of follicle-stimulating hormone for the treatment of female infertility - current concepts, Womens Health (Lond) 1(1): 87–95.
  14. Casarini L, et al. 2020: FSH for the treatment of male infertility, Int J Mol Sci. 21(7): 2270.
  15. Hascalik S, et al. 2010: Effects of highly purified urinary FSH and human menopausal FSH on uterine myoelectrical dynamics, Mol Hum Reprod. 16(3): 200–6.
  16. Phipps WR, et al. 1996: Use of recombinant human follicle-stimulating hormone for in vitro fertilization-embryo transfer after severe systemic immunoglobulin E-mediated reaction to urofollitropin, Fertil Steril. 66(1): 148–50.
  17. Riccetti L, et al. 2019: Glycosylation pattern and in vitro bioactivity of reference follitropin alfa and biosimilars, Front Endocrinol (Lausanne) 10: 503.
  18. Casarini L, Simoni M. 2021: Recent advances in understanding gonadotropin signaling, Fac Rev. 10: 41.
  19. Rose TH, et al. 2016: Characterisation of population pharmacokinetics and endogenous follicle-stimulating hormone (FSH) levels after multiple dosing of a recombinant human FSH (FE 999049) in healthy women, Drugs R D. 16(2): 165–72.
  20. Das N, et al. 2018: Molecular regulation of follicle-stimulating hormone synthesis, secretion and action, J Mol Endocrinol. 60(3): R131–55.

Jiagen Biotechnologies supplies quality Follicle Stimulating Hormone (FSH) of various specifications.
Contact us at sales@jiagen.ca to place an order.

Order